Glucarpidase Effect on Severe Delayed HDM-clearance in Children Treated With High-dose Mtx in ALL

NCT01305655 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia (ALL)

Interventions

DRUG: Glucarpidase

Sponsor

Nordic Society for Pediatric Hematology and Oncology

Collaborators

[object Object]